Pharmafile Logo

dual tasking

- PMLiVE

UN report highlights role of pharma pollution in growing antimicrobial resistance threat

WHO lists AMR as one of ten top threats to global health, causing 1.27 million deaths in 2019

- PMLiVE

Eiger BioPharmaceuticals reports positive phase 3 results for COVID-19 treatment

Peginterferon lambda showed a 51% reduction in hospitalisations or emergency room visits

- PMLiVE

Bayer AG appoints Bill Anderson as new CEO

Anderson was most recently CEO of Roche’s pharmaceuticals division

- PMLiVE

A new age of innovation in healthcare

The long-term potential of approaching healthcare challenges and opportunities with a new creative spirit is something that goes way beyond technical reach

- PMLiVE

Innovative HCP user experience earns award for Medthority platform

EPG Health’s medical education website has been recognised for its HCP-centric design.

EPG Health

Infographic: Living with: The journey from the patient’s perspective

View our re-vamped interactive infographic to unlock key insights from various Living With reports

Inizio

Case study: How we iteratively tested and refined payer value messages

Find out how we helped our client to enrich their understanding of the value message trade-off choices and preferences made by payers

Inizio

- PMLiVE

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education

- PMLiVE

Mental health in PR: New industry-wide CPD-accredited training programme launches to help manage work-related pressure and stress

Fox&cat, CIPR, PRCA and HCA launch Under the tree: a free training programme designed to equip agency, in-house and independent communications practitioners with the skills they need to manage work-related...

Fox&Cat

- PMLiVE

AstraZeneca’s heart failure treatment approved for expanded use in EU

Chronic heart failure is the leading cause of hospitalisation for those over the age of 65

- PMLiVE

Roche reports positive results for crovalimab as rare blood disease treatment

The drug was shown to be as effective as current treatment, with less frequent dosing

- PMLiVE

HCA collaborates on new mental health initiative for communications professionals

A recent report showed over 90% of PR professionals experienced poor mental health in 2022

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links